2024 ESC guidelines for the management of chronic coronary syndromes: developed by the task force for the management of chronic coronary syndromes of the …
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …
off-label use of medication should be limited to situations where it is in the patient's interest …
Metabolic syndrome
IJ Neeland, S Lim, A Tchernof, A Gastaldelli… - Nature Reviews …, 2024 - nature.com
The metabolic syndrome (MetS) is a multiplex modifiable risk factor for cardiovascular
disease, type 2 diabetes mellitus and other health outcomes, and is a major challenge to …
disease, type 2 diabetes mellitus and other health outcomes, and is a major challenge to …
Ceramides and other sphingolipids as drivers of cardiovascular disease
Increases in calorie consumption and sedentary lifestyles are fuelling a global pandemic of
cardiometabolic diseases, including coronary artery disease, diabetes mellitus …
cardiometabolic diseases, including coronary artery disease, diabetes mellitus …
Ceramides in metabolism: key lipotoxic players
B Chaurasia, SA Summers - Annual review of physiology, 2021 - annualreviews.org
The global prevalence of metabolic diseases such as type 2 diabetes mellitus,
steatohepatitis, myocardial infarction, and stroke has increased dramatically over the past …
steatohepatitis, myocardial infarction, and stroke has increased dramatically over the past …
Effect of urolithin A supplementation on muscle endurance and mitochondrial health in older adults: a randomized clinical trial
S Liu, D D'Amico, E Shankland, S Bhayana… - JAMA network …, 2022 - jamanetwork.com
Importance Aging is associated with a decline in mitochondrial function and reduced
exercise capacity. Urolithin A is a natural gut microbiome–derived food metabolite that has …
exercise capacity. Urolithin A is a natural gut microbiome–derived food metabolite that has …
Machine learning reveals serum sphingolipids as cholesterol-independent biomarkers of coronary artery disease
BACKGROUND Ceramides are sphingolipids that play causative roles in diabetes and heart
disease, with their serum levels measured clinically as biomarkers of cardiovascular disease …
disease, with their serum levels measured clinically as biomarkers of cardiovascular disease …
Recent advances in analytical strategies for mass spectrometry-based lipidomics
T Xu, C Hu, Q Xuan, G Xu - Analytica chimica acta, 2020 - Elsevier
Lipids are vital biological molecules and play multiple roles in cellular function of
mammalian organisms such as cellular membrane anchoring, signal transduction, material …
mammalian organisms such as cellular membrane anchoring, signal transduction, material …
Genome-wide association analysis of plasma lipidome identifies 495 genetic associations
L Ottensmann, R Tabassum, SE Ruotsalainen… - Nature …, 2023 - nature.com
The human plasma lipidome captures risk for cardiometabolic diseases. To discover new
lipid-associated variants and understand the link between lipid species and cardiometabolic …
lipid-associated variants and understand the link between lipid species and cardiometabolic …
Ceramide metabolism in cardiovascular disease: a network with high therapeutic potential
A Zietzer, P Düsing, L Reese, G Nickenig… - … , and Vascular Biology, 2022 - Am Heart Assoc
Growing evidence suggests that ceramides play an important role in the development of
atherosclerotic and valvular heart disease. Ceramides are biologically active sphingolipids …
atherosclerotic and valvular heart disease. Ceramides are biologically active sphingolipids …
Intake and metabolism of omega-3 and omega-6 polyunsaturated fatty acids: nutritional implications for cardiometabolic diseases
MB Schulze, AM Minihane, RNM Saleh… - The Lancet Diabetes & …, 2020 - thelancet.com
Prospective observational studies support the use of long-chain omega-3 polyunsaturated
fatty acids (PUFAs) in the primary prevention of atherosclerotic cardiovascular disease; …
fatty acids (PUFAs) in the primary prevention of atherosclerotic cardiovascular disease; …